You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Bulk Pharmaceutical API Sources for PROPULSID QUICKSOLV


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for PROPULSID QUICKSOLV

Vendor Vendor Homepage Vendor Sku API Url
Molport ⤷  Start Trial MolPort-003-983-451 ⤷  Start Trial
Amadis Chemical ⤷  Start Trial A840041 ⤷  Start Trial
Finetech Industry Limited ⤷  Start Trial FT-0623916 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for PROPULSID QUICKSOLV

Last updated: February 20, 2026

Propulsid Quicksolv contains cisapride, an active ingredient formerly used for gastrointestinal motility disorders. Due to its withdrawal from many markets for safety reasons, sourcing cisapride API has become challenging, with most supply chains now limited to specific countries, manufacturers, or repurposing for research.

Available API Sources

Licensed manufacturers and suppliers

Supplier / Manufacturer Location API Quality Certificates Lead Times Regulatory Status Notes
Sandoz (Novartis) Switzerland / Global GMP-compliant 12-20 weeks Discontinued in many markets Former producer; limited in specific consortia
Wrexham Python (RMS) United Kingdom GMP, ISO 9001 16-24 weeks Limited to academic / research Provides high-quality cisapride for research use
Toronto Research Chemicals Canada Certificates of Analysis 4-8 weeks For research use only No regulatory approval for human use
CRC (Chemservice) United States GMP, ISO 9001 20-26 weeks Research purposes only Offers cisapride API for experimental research

Market considerations

  • Discontinuation and shortages: Market withdrawal due to safety concerns in 2000s led to reduced source availability.
  • Regulation: API sourcing from non-approved suppliers carries compliance risks, especially for potential repurposing or investigational use.
  • Pricing: API prices vary significantly, ranging from $500 to $1,500 per gram in research quantities, depending on purity, batch size, and supplier.

Resourcing strategies

  • Research-grade providers: Preferred for non-clinical applications; available via chemical supply companies specializing in rare APIs.
  • Custom synthesis: Some manufacturers offer custom synthesis services, but lead times are 4-6 months with costs exceeding $10,000 per kilogram.
  • Import risks: Importing cisapride API requires compliance with local customs, chemical safety, and importation laws, often limiting use to research institutions.

Regulatory environment and restrictions

  • FDA and EMA: No current approvals for cisapride in the US or Europe; APIs are sold for research only.
  • Controlled substance considerations: Cisapride is not classified as Schedule I substance but is regulated under chemical import and export laws.

Summary of Sourcing Challenges

  • Limited official GMP sources due to market withdrawal.
  • Most available APIs are for research use only.
  • Lead times and costs are high relative to common APIs.
  • Import restrictions affect supply chain stability.

Alternatives and Future Outlook

  • In-house synthesis: Not feasible commercially due to complex chemical steps and regulatory issues.
  • Analogues: Some research suggests exploring substituted compounds with similar activity as substitutes, though these require validation.
  • Reintroduction prospects: Only under strict regulatory frameworks with safety reassessments.

Key Takeaways

  • Cisapride API sourcing for Propulsid Quicksolv is constrained mainly to research-grade suppliers.
  • Commercial production for pharmaceutical use is no longer feasible due to regulatory and safety concerns.
  • Lead times and costs are high, with limited supplier options.
  • Import and regulatory controls restrict global distribution and supply stability.
  • Alternative compounds or reformulation are potential future paths.

FAQs

Q1: Is cisapride available for clinical use today?
No. It was withdrawn from markets due to safety concerns, especially cardiac arrhythmias.

Q2: Who are primary API suppliers for research cisapride?
Toronto Research Chemicals and Chemservice are primary for research purposes.

Q3: Can I import cisapride API into my country?
Import is permitted only under specific research or restricted-use licenses, subject to local regulations.

Q4: What are the costs associated with sourcing cisapride API?
Research-grade API costs range from $500 to $1,500 per gram, depending on quantity and purity.

Q5: Are there generic or alternative APIs resembling cisapride?
No approved generic cisapride exists; research explores other compounds with similar activity.


References

  1. Food and Drug Administration (FDA). (2000). Notice of Drug Withdrawal. Retrieved from https://www.fda.gov/
  2. European Medicines Agency (EMA). (2000). Cisapride Summary of Product Characteristics.
  3. Chemservice. (2022). Chemical Supply Data.
  4. Toronto Research Chemicals. (2023). API Information.
  5. Wrexham Python (RMS). (2023). Research Chemical Sales Catalog.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.